Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Firmani Lori
Chief Financial Officer at Damora Therapeutics. Filing since 3 Jan 2025.
CIK 0001808248
Company
Date
Role
Action
Shares
Amount
Of holding
DMRA
Damora Therapeutics, Inc.
2 Jan 2026
Chief Financial Officer
Sold at will
135
$2.89K
12.7%
DMRA
Damora Therapeutics, Inc.
3 Jul 2025
Interim CFO
Sold at will
147
$498.33
17.5%
DMRA
Damora Therapeutics, Inc.
3 Jan 2025
Interim CFO
Sold at will
261
$1.47K
36.0%
3 decisions on file.